1 1

Medical Education Hub

Memorial Sloan Kettering Cancer Center 9th Annual Advances in Colorectal Oncology 2025

Memorial Sloan Kettering Cancer Center 9th Annual Advances in Colorectal Oncology 2025

€50,00 EUR
€50,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.

Memorial Sloan Kettering Cancer Center 9th Annual Advances in Colorectal Oncology 2025

+ Include: 21 videos + 21 pdf, size: 8.04 GB
+ Target Audience: medical oncologists, radiation oncologists, interventional radiologists, colorectal/hepatopancreatobiliary/oncologic surgeons, gastroenterologists, pathologists
+ Information:
Date & Location Thursday, November 6, 2025, 8:00 AM – Friday, November 7, 2025, 5:30 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY
Specialties – Clinical Pathology, Colorectal Surgery, Gastroenterology, Gastrointestinal Oncology, General Surgery, Interventional Radiology, Medical Oncology, Pathology, Radiation Oncology, Solid Tumor Oncology, Surgical Oncology, Surgical Pathology
Overview

This two-day live symposium at Memorial Sloan Kettering Cancer Center will focus on the surgical and multidisciplinary management of colorectal cancer. National and international leaders in surgery, medical oncology, and radiation oncology will address current controversies and highlight emerging approaches in the treatment of both localized and metastatic disease.

Highlights of this year’s program include:
  • Live surgery presentations streamed directly from MSK’s operating rooms
  • Focused sessions exploring current controversies in the medical and surgical management of rectal cancer, with a focus on TNT and Watch-and-Wait approaches
  • Cutting edge updates in the treatment of colorectal malignancies, including advances in KRAS and BRAF targeted therapies
  • Reviews of recent clinical trials in colon, rectal, and anal cancers
  • Interactive multidisciplinary tumor boards featuring complex case discussions
  • Networking opportunities to connect with leading experts and peers

This comprehensive program is designed to equip participants with the latest evidence-based strategies and multidisciplinary perspectives that are shaping the future of colorectal cancer care—ultimately advancing clinical practice and improving patient outcomes.

Target Audience: This symposium is intended for medical oncologists, radiation oncologists, interventional radiologists, colorectal/hepatopancreatobiliary/oncologic surgeons, gastroenterologists, pathologists, and other oncology care team members interested in rectal cancer. A virtual attendance option is available for those unable to join us in New York City.

Post-Symposium Resources: All registered participants will also receive access to an online syllabus following the symposium, which will include presentation recordings and faculty slide decks in PDF format.
Objectives
At the conclusion of this symposium, attendees will be able to:
  1. Describe the requirements for a successful, multidisciplinary colorectal cancer program
  2. Discuss technical options for the surgical management of distal rectal cancer
  3. Identify appropriate candidates for Watch and Wait and adjuncts to optimize organ preservation
  4. Discuss evidence-based practice recommendation for the management of metastatic colorectal cancer
  5. Review advancements in immunotherapy and alternative strategies for managing colorectal cancer

 

+ Topics:

Thursday, November 6, 2025

Colorectal General Session

Only PDFs and videos consented to by faculty are available below. Multidisciplinary Tumor Boards will not be posted on the online syllabus.

Is There Still a Role forLaparoscopic TaTME?
  • 1:30PM – 1:45PM
  • Patricia Sylla, MD, FACS, FASCRS
When There is No Room for Stapling: Coloanal Anastomois or APR?
  • 1:45PM – 2:00PM
  • Martin R. Weiser, MD
Managing the Perineal Wound After APR: Primary Closure, Mesh, or Flaps?
  • 2:00PM – 2:15PM
  • Emmanouil Pappou, MD,PhD
Salvage Local Excision for Incomplete Responders: Are We Pushing Organ Preservation Too Far?
  • 2:15PM – 2:30PM
  • Geerard Beets, MD, PhD, Professor of Surgical Oncology
Brachytherapy for Incomplete Response After Neoadjuvant Therapy: When and How?
  • 2:30PM – 2:45PM
  • Abraham J. J Wu, MD
Controversies in the Surgical Management of Distal Rectal Cancer in the Era of TNT and Watch-and-Wait – Q&A and Panel Discussion
  • 2:45PM – 3:15PM
  • Georgios Karagkounis, MD (Moderator)
  • Iris H. Wei, MD (Moderator)

Friday, November 7, 2025

The Harbinger’s Dilemma: ctDNA in Colorectal Cancer
  • 8:05AM – 9:00AM
  • Scott Kopetz, MD, PhD

 

Management Options for Intermediate Risk Mid Rectal Cancer
  • 9:00AM – 9:25AM
  • Leonard B Saltz, MD
  • Jurriaan Tuynman, MD, PhD
  • Neoadjuvant Therapy for Everyone — Leonard Saltz, MDNeoadjuvant Therapy is Rarely Neccesary — Jurriaan Tuynman, MD, PhD

 

Near Complete Response After Neoadjuvant Therapy for Locally Advanced Rectal Cancer
  • 9:25AM – 9:50AM
  • Maria Widmar, MD, Assistant Attending
  • Iris H. Wei, MD
  • Surgery Now — Iris H. Wei, MD, FACSNo Need to Rush to the OR — Maria Widmar, MD, MPH 
Neoadjuvant Chemotherapy for pMMR Locally Advanced Colon Cancer
  • 9:50AM – 10:15AM
  • Alessandro Fichera, MD, FACS, FASCRS, FISS, FCCF
  • Anwaar Saeed, MD
  • Pro — Anwaar Saeed, MDCon — Alessandro Fichera, MD 
New Immuno-Oncology Strategies in Colorectal Cancer
  • 10:15AM – 10:40AM
  • Vinod Balachandran, MD, Associate Member
  • Kai-Keen Shiu, MBBS, PhD, FRCP
  • Immune Checkpoint Blockade in pMMR Colon and Rectal Cancer — Kai-Keen Shiu, PhD, FRCPmRNA Vaccines — Vinod P. Balachandran, MD (Please note, slides are not
  • available for this presentation) 
Structured Exercise to Reduce Colorectal Cancer Recurrence
  • 11:00AM – 11:15AM
  • Jessica Scott, PhD
ctDNA Testing to Guide Colorectal Cancer Management: Is The Time Now?
  • 11:15AM – 11:30AM
  • Luis Diaz Jr., MD
Colorectal Cancer Plasticity and Evolution
  • 11:30AM – 11:45AM
  • Karuna Ganesh, MD
Genome Driven Treatment of Metastatic Colorectal Cancer
  • 11:45AM – 12:00PM
  • Rona Yaeger, MD
New Therapies for Refractory dMMR Metastatic Colorectal Cancer
  • 12:00PM – 12:15PM
  • Michael Foote, MD
Aspirin for Chemoprevention in Early Stage Colorectal Cancer
  • 12:15PM – 12:30PM
  • Andrew T Chan, MD, MPH
The REAL Trial
  • 1:30PM – 2:00PM
  • Geerard Beets, MD, PhD, Professor of Surgical Oncology (Panelist)
  • Qingyang Feng, MD, Associate Professor (Presenter)
TESAR Trial
  • 2:00PM – 2:30PM
  • Martin R. Weiser, MD (Panelist)
  • Jurriaan Tuynman, MD, PhD (Presenter)
Stellar 303
  • 2:30PM – 3:00PM
  • Neil H. H Segal, MD, PhD (Panelist)
  • Anwaar Saeed, MD (Presenter)
Pod1um 303
  • 3:00PM – 3:30PM
  • Maliha Nusrat, MBBS (Panelist)
  • Sheela Rao, MBBS, MD, FRCP, Consultant Medical Oncologist, Reader in Gastrointestinal Cancers (Presenter)
View full details